Shares of Eurofins Scient (OTCMKTS:ERFSF – Get Free Report) have earned an average recommendation of “Moderate Buy” from the six analysts that are covering the company, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation, one has given a buy recommendation and one has given a strong buy recommendation to the company.
A number of research analysts recently issued reports on the stock. BNP Paribas Exane raised shares of Eurofins Scient to an “outperform” rating in a research report on Monday, January 5th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Eurofins Scient in a research note on Wednesday, October 29th. Finally, Citigroup reiterated a “neutral” rating on shares of Eurofins Scient in a report on Wednesday, October 22nd.
Get Our Latest Report on Eurofins Scient
Eurofins Scient Stock Performance
Eurofins Scient Company Profile
Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.
Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.
Featured Articles
- Five stocks we like better than Eurofins Scient
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Eurofins Scient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eurofins Scient and related companies with MarketBeat.com's FREE daily email newsletter.
